XML 58 R49.htm IDEA: XBRL DOCUMENT v3.26.1
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Payables and Accruals [Abstract]    
Product revenue allowances $ 11,115 $ 9,810
Accrued clinical study and trial costs 20,878 18,977
Accrued selling, general, and administrative costs 6,483 6,316
Accrued compensation and related costs 11,384 24,352
Accrued milestone costs 0 10,000
Accrued interest - royalty interest financing 34,149 25,516
Accrued interest - convertible note 555 0
Accrued royalty payable 8,183 7,372
Other 1,550 721
Total accrued expenses and other current liabilities $ 94,297 $ 103,064